317 Coalition
Pharmaceutical Coalition
Based in DC
🤖
AI Overview
With $330K in lobbying spend across 10 quarterly filings, 317 Coalition is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.
$330K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $100K |
| 2025 | $230K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
- •Supporting increased funding for the CDC National Immunization Program (Sec. 317 Program)
- •Support increased funding for the CDC National Immunization Program (Sec 317 program).
- •Support increased funding for the CDC National Immunization Program (Sec 317 program)
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.